Bio Haven: How Yale and New Haven are building a future together
New Haven’s biotech community has seen fits and starts, but today it is achieving critical mass. Upwards of 50 biotech and medical device companies employ more than 5,000 people in greater New Haven. Yale School of Medicine has been instrumental in the communty's growth.
Yale Cancer Center Experts Present New Research at Hematology Annual Meeting
Physicians and scientists from Yale Cancer Center, part of Yale School of Medicine, will present new research at the 65th American Society of Hematology (ASH) Annual Meeting and Exposition in San Diego, Calif., from December 9 to 12.
Yale Researchers Develop New Testing Criteria for Hereditary Stomach Cancer
Yale researchers have shown that individuals who carry a mutation in the CDH1 gene have a 30% to 40% risk of developing stomach cancer during their lifetime. Yet many people with the rare inherited condition remain unaware that they have it.
Yale scientists chosen by White House to expedite cancer research
Yale is one of three institutions that have been honored with the White House Cancer Moonshot research grant. Yale's Douglas Hanlon, PhD, research scientist in dermatology, and Richard Edelson, MD, the Anthony N. Brady Professor of Dermatology, describe their groundbreaking research, using mRNA technology to create a vaccine that targets only cancer cells.Source: WTNH News 8
YSPH alumna Margaret Mayer embraces challenge of grant management at the National Cancer Institute
This Alumni Spotlight focuses on Margaret Mayer, PhD ’19 (Chronic Disease Epidemiology), MPH ’16 (Chronic Disease Epidemiology), the program director in the Tobacco Cancer Research Branch at the National Cancer Institute.
Overdiagnosis and Preventative Screening: A Q&A With Ilana Richman
In a Q&A, Ilana Richman, MD, MHS, assistant professor of medicine (general medicine), discusses why overdiagnosis is a concern, the challenges of assessing the benefit of new screening technologies, and the risks and benefits people should weigh when considering preventative screening.
Sang Taek Kim Returns to YSM to Lead Immunotherapy Adverse Events Program
A physician scientist, Sang Taek Kim, MD, PhD, assistant professor of medicine (rheumatology), is interested in the autoimmune complications induced by cancer immunotherapy. In his new role, he serves as director of the Immunotherapy Adverse Events in Rheumatology Program.
Transitioning Cancer Survivors Away From Oncologic Care
October was Breast Cancer Awareness month and the sudden influx of pink in our homes, on our televisions, in our workplaces, and in local businesses reminded us that we still lose far too many of our loved ones to cancer, not only in this form but in so many others. While the race to discover new diagnostics and treatments remains imperative, there is another pressing issue emerging for patients with cancer. With advances in early detection, treatment, and oncologic outcomes, many individuals diagnosed with cancer are now living longer and are thus more likely to die from or develop conditions other than cancer. Two thirds of all individuals diagnosed with cancer now live 5 years or more past diagnosis, and the number of such "long-term" survivors in the U.S. will rise from 15.5 million to 20 million by 2026. As such, there is a pressing need to encourage the shift in survivorship care away from oncologists back to primary care physicians and other non-oncologists.Source: MedPage Today
Offering Specialized Care & Research For Patients with Cancer and HIV
Patients living at this unique intersection of HIV and cancer face complex medical challenges, and traditional cancer care pathways often do not effectively address the specific needs of individuals with HIV. Brinda Emu, MD, PhD, associate professor of medicine (infectious diseases), and Jill Lacy, MD, professor of medicine (medical oncology), realized that a dedicated effort was required to offer comprehensive care, as well as investigate the scientific underpinnings of these conditions.
Witches and Mombies! Happy Halloween from Where We Live
The “Mombies” is a group of Moms of all ages that have been coordinating to “dance to donate” since 2016. They have raised over $170,000 for breast cancer research to date - and their dance videos have been seen by millions.Source: CT Public
Yale Program Treats Individuals at High Risk for Gastrointestinal and Pancreatic Cancers
Yale’s Digestive Health Center, a hub offering advanced medical and surgical treatments for individuals with gastrointestinal issues, recently opened the Gastrointestinal (GI) and Pancreatic Cancer Prevention Program at its North Haven location.